|
|
Prepublished online as a Blood First Edition Paper on October 31, 2002; DOI 10.1182/blood-2002-08-2502.
 Previous Article | Table of Contents | Next Article 
Blood, 1 April 2003, Vol. 101, No. 7, pp. 2686-2692
IMMUNOBIOLOGY
Primary immune responses to human CMV: a critical role for
IFN- -producing CD4+ T cells in protection against CMV
disease
Laila E. Gamadia,
Ester B. M. Remmerswaal,
Jan F. Weel,
Frederieke Bemelman,
René A. W. van
Lier, and
Ineke J. M. Ten
Berge
From the Renal Transplant Unit, Department of Internal
Medicine, Laboratory for Experimental Immunology, Department of
Virology, and Division of Clinical Immunology and Rheumatology,
Academic Medical Center, Amsterdam, The Netherlands.
The correlates of protective immunity to disease-inducing
viruses in humans remain to be elucidated. We determined the kinetics and characteristics of cytomegalovirus (CMV)-specific
CD4+ and CD8+ T cells in the course of primary
CMV infection in asymptomatic and symptomatic recipients of renal
transplants. Specific CD8+ cytotoxic T lymphocyte
(CTL) and antibody responses developed regardless of clinical signs.
CD45RA CD27+CCR7 CTLs,
although classified as immature effector cells in HIV
infection, were the predominant CD8 effector population in the acute
phase of protective immune reactions to CMV and were functionally
competent. Whereas in asymptomatic individuals the CMV-specific
CD4+ T-cell response preceded CMV-specific CD8+
T-cell responses, in symptomatic individuals the CMV-specific effector-memory CD4+ T-cell response was delayed and only
detectable after antiviral therapy. The appearance of disease symptoms
in these patients suggests that functional CD8+ T-cell and
antibody responses are insufficient to control viral replication and
that formation of effector-memory CD4+ T cells is necessary
for recovery of infection.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. K. L. Cheung, D. J. Gottlieb, B. Plachter, S. Pepperl-Klindworth, S. Avdic, A. L. Cunningham, A. Abendroth, and B. Slobedman
The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency
Blood,
November 5, 2009;
114(19):
4128 - 4137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Cantisan, J. Torre-Cisneros, R. Lara, A. Rodriguez-Benot, F. Santos, J. Gutierrez-Aroca, I. Gayoso, M. Gonzalez-Padilla, M. Casal, A. Rivero, et al.
Age-Dependent Association between Low Frequency of CD27/CD28 Expression on pp65 CD8+ T Cells and Cytomegalovirus Replication after Transplantation
Clin. Vaccine Immunol.,
October 1, 2009;
16(10):
1429 - 1438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kondo, H. Takata, F. Matsuki, and M. Takiguchi
Cutting Edge: Phenotypic Characterization and Differentiation of Human CD8+ T Cells Producing IL-17
J. Immunol.,
February 15, 2009;
182(4):
1794 - 1798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Walker, C. L. Maier, and J. S. Pober
Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes
J. Immunol.,
February 1, 2009;
182(3):
1548 - 1559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Crough and R. Khanna
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Clin. Microbiol. Rev.,
January 1, 2009;
22(1):
76 - 98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Libri, D. Schulte, A. van Stijn, J. Ragimbeau, L. Rogge, and S. Pellegrini
Jakmip1 Is Expressed upon T Cell Differentiation and Has an Inhibitory Function in Cytotoxic T Lymphocytes
J. Immunol.,
November 1, 2008;
181(9):
5847 - 5856.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sacre, S. Nguyen, C. Deback, G. Carcelain, J.-P. Vernant, V. Leblond, B. Autran, and N. Dhedin
Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation
J. Virol.,
October 15, 2008;
82(20):
10143 - 10152.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Baron and J.-L. Davignon
Inhibition of IFN-{gamma}-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2
J. Immunol.,
October 15, 2008;
181(8):
5530 - 5536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Pitard, D. Roumanes, X. Lafarge, L. Couzi, I. Garrigue, M.-E. Lafon, P. Merville, J.-F. Moreau, and J. Dechanet-Merville
Long-term expansion of effector/memory V{delta}2- {gamma}{delta} T cells is a specific blood signature of CMV infection
Blood,
August 15, 2008;
112(4):
1317 - 1324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Walton, P. Wyrsch, M. W. Munks, A. Zimmermann, H. Hengel, A. B. Hill, and A. Oxenius
The Dynamics of Mouse Cytomegalovirus-Specific CD4 T Cell Responses during Acute and Latent Infection
J. Immunol.,
July 15, 2008;
181(2):
1128 - 1134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Pipeling, E. E. West, C. M. Osborne, A. B. Whitlock, L. K. Dropulic, M. H. Willett, M. Forman, A. Valsamakis, J. B. Orens, D. R. Moller, et al.
Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate over the Blood during Human Primary Infection
J. Immunol.,
July 1, 2008;
181(1):
546 - 556.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. van Stijn, A. T. Rowshani, S. L. Yong, F. Baas, E. Roosnek, I. J. M. ten Berge, and R. A. W. van Lier
Human Cytomegalovirus Infection Induces a Rapid and Sustained Change in the Expression of NK Cell Receptors on CD8+ T Cells
J. Immunol.,
April 1, 2008;
180(7):
4550 - 4560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Price, A. D. Bitmansour, J. B. Edgar, J. M. Walker, M. K. Axthelm, D. C. Douek, and L. J. Picker
Induction and Evolution of Cytomegalovirus-Specific CD4+ T Cell Clonotypes in Rhesus Macaques
J. Immunol.,
January 1, 2008;
180(1):
269 - 280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Onion, L. J. Crompton, D. W. Milligan, P. A. H. Moss, S. P. Lee, and V. Mautner
The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein
J. Gen. Virol.,
September 1, 2007;
88(9):
2417 - 2425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Delmas, P. Brousset, D. Clement, E. Le Roy, and J.-L. Davignon
Anti-IE1 CD4+ T-cell clones kill peptide-pulsed, but not human cytomegalovirus-infected, target cells
J. Gen. Virol.,
September 1, 2007;
88(9):
2441 - 2449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. C. Miles, M. van der Sande, D. Jeffries, S. Kaye, J. Ismaili, O. Ojuola, M. Sanneh, E. S. Touray, P. Waight, S. Rowland-Jones, et al.
Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation
J. Virol.,
June 1, 2007;
81(11):
5766 - 5776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing
Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation
J. Virol.,
May 1, 2007;
81(9):
4389 - 4396.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Khan, D. Best, R. Bruton, L. Nayak, A. B. Rickinson, and P. A. H. Moss
T Cell Recognition Patterns of Immunodominant Cytomegalovirus Antigens in Primary and Persistent Infection
J. Immunol.,
April 1, 2007;
178(7):
4455 - 4465.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Casazza, M. R. Betts, D. A. Price, M. L. Precopio, L. E. Ruff, J. M. Brenchley, B. J. Hill, M. Roederer, D. C. Douek, and R. A. Koup
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
J. Exp. Med.,
December 25, 2006;
203(13):
2865 - 2877.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Kasprowicz, A. Isa, T. Tolfvenstam, K. Jeffery, P. Bowness, and P. Klenerman
Tracking of Peptide-Specific CD4+ T-Cell Responses after an Acute Resolving Viral Infection: a Study of Parvovirus B19
J. Virol.,
November 15, 2006;
80(22):
11209 - 11217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. M. van Leeuwen, J. J. Koning, E. B. M. Remmerswaal, D. van Baarle, R. A. W. van Lier, and I. J. M. ten Berge
Differential Usage of Cellular Niches by Cytomegalovirus versus EBV- and Influenza Virus-Specific CD8+ T Cells
J. Immunol.,
October 15, 2006;
177(8):
4998 - 5005.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Zaunders, W. B. Dyer, M. L. Munier, S. Ip, J. Liu, E. Amyes, W. Rawlinson, R. De Rose, S. J. Kent, J. S. Sullivan, et al.
CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells.
J. Virol.,
October 1, 2006;
80(20):
10151 - 10161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Zaunders, S. Ip, M. L. Munier, D. E. Kaufmann, K. Suzuki, C. Brereton, S. C. Sasson, N. Seddiki, K. Koelsch, A. Landay, et al.
Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection.
J. Virol.,
October 1, 2006;
80(20):
10162 - 10172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-D. Park, L. Marti, J. Kurtzberg, and P. Szabolcs
In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes
Blood,
September 1, 2006;
108(5):
1770 - 1773.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. A. Shlobin, E. E. West, N. Lechtzin, S. M. Miller, M. Borja, J. B. Orens, L. K. Dropulic, and J. F. McDyer
Persistent Cytomegalovirus-Specific Memory Responses in the Lung Allograft and Blood following Primary Infection in Lung Transplant Recipients
J. Immunol.,
February 15, 2006;
176(4):
2625 - 2634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Perruccio, A. Tosti, E. Burchielli, F. Topini, L. Ruggeri, A. Carotti, M. Capanni, E. Urbani, A. Mancusi, F. Aversa, et al.
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
Blood,
December 15, 2005;
106(13):
4397 - 4406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Delmas, L. Martin, M. Baron, J. A. Nelson, D. N. Streblow, and J.-L. Davignon
Optimization of CD4+ T Lymphocyte Response to Human Cytomegalovirus Nuclear IE1 Protein through Modifications of Both Size and Cellular Localization
J. Immunol.,
November 15, 2005;
175(10):
6812 - 6819.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Piriou, K. van Dort, N. M. Nanlohy, M. H. J. van Oers, F. Miedema, and D. van Baarle
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma
Blood,
November 1, 2005;
106(9):
3166 - 3174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. R. Hegde, C. Dunn, D. M. Lewinsohn, M. A. Jarvis, J. A. Nelson, and D. C. Johnson
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL
J. Exp. Med.,
October 17, 2005;
202(8):
1109 - 1119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. M. van Leeuwen, G. J. de Bree, E. B. M. Remmerswaal, S.-L. Yong, K. Tesselaar, I. J. M. t. Berge, and R. A. W. van Lier
IL-7 receptor {alpha} chain expression distinguishes functional subsets of virus-specific human CD8+ T cells
Blood,
September 15, 2005;
106(6):
2091 - 2098.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. Sylwester, B. L. Mitchell, J. B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P. R. Sleath, K. H. Grabstein, N. A. Hosken, F. Kern, et al.
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
J. Exp. Med.,
September 6, 2005;
202(5):
673 - 685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Piriou, C. A. Jansen, K. v. Dort, I. De Cuyper, N. M. Nanlohy, J. M. A. Lange, M. H. J. van Oers, F. Miedema, and D. van Baarle
Reconstitution of EBV Latent but Not Lytic Antigen-Specific CD4+ and CD8+ T Cells after HIV Treatment with Highly Active Antiretroviral Therapy
J. Immunol.,
August 1, 2005;
175(3):
2010 - 2017.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sacre, G. Carcelain, N. Cassoux, A.-M. Fillet, D. Costagliola, D. Vittecoq, D. Salmon, Z. Amoura, C. Katlama, and B. Autran
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease
J. Exp. Med.,
June 20, 2005;
201(12):
1999 - 2010.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. P. M. Koenen, E. Fasse, and I. Joosten
CD27/CFSE-Based Ex Vivo Selection of Highly Suppressive Alloantigen-Specific Human Regulatory T Cells
J. Immunol.,
June 15, 2005;
174(12):
7573 - 7583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Weekes, M. R. Wills, J. G. P. Sissons, and A. J. Carmichael
Long-Term Stable Expanded Human CD4+ T Cell Clones Specific for Human Cytomegalovirus Are Distributed in Both CD45RAhigh and CD45ROhigh Populations
J. Immunol.,
November 1, 2004;
173(9):
5843 - 5851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. M. van Leeuwen, E. B. M. Remmerswaal, M. T. M. Vossen, A. T. Rowshani, P. M. E. Wertheim-van Dillen, R. A. W. van Lier, and I. J. M. ten Berge
Emergence of a CD4+CD28- Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection
J. Immunol.,
August 1, 2004;
173(3):
1834 - 1841.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Gamadia, E. M. M. van Leeuwen, E. B. M. Remmerswaal, S.-L. Yong, S. Surachno, P. M. E. Wertheim-van Dillen, I. J. M. ten Berge, and R. A. W. van Lier
The Size and Phenotype of Virus-Specific T Cell Populations Is Determined by Repetitive Antigenic Stimulation and Environmental Cytokines
J. Immunol.,
May 15, 2004;
172(10):
6107 - 6114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Li Pira, L. Bottone, F. Ivaldi, R. Pelizzoli, F. Del Galdo, L. Lozzi, L. Bracci, A. Loregian, G. Palu, R. De Palma, et al.
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution
Int. Immunol.,
May 1, 2004;
16(5):
635 - 642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Zaunders, W. B. Dyer, B. Wang, M. L. Munier, M. Miranda-Saksena, R. Newton, J. Moore, C. R. Mackay, D. A. Cooper, N. K. Saksena, et al.
Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection
Blood,
March 15, 2004;
103(6):
2238 - 2247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Baldanti, D. Lilleri, G. Campanini, G. Comolli, A. L. Ridolfo, S. Rusconi, and G. Gerna
Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response
J. Antimicrob. Chemother.,
March 1, 2004;
53(3):
536 - 539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Tu, S. Chen, M. Sharp, C. Dekker, A. M. Manganello, E. C. Tongson, H. T. Maecker, T. H. Holmes, Z. Wang, G. Kemble, et al.
Persistent and Selective Deficiency of CD4+ T Cell Immunity to Cytomegalovirus in Immunocompetent Young Children
J. Immunol.,
March 1, 2004;
172(5):
3260 - 3267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gibson, G. Piccinini, D. Lilleri, M. G. Revello, Z. Wang, S. Markel, D. J. Diamond, and K. Luzuriaga
Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection
J. Immunol.,
February 15, 2004;
172(4):
2256 - 2264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. R. Godfrey, M. R. Krampf, P. A. Taylor, and B. R. Blazar
Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation
Blood,
February 1, 2004;
103(3):
1158 - 1165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Popkin and H. W. Virgin IV
Murine Cytomegalovirus Infection Inhibits Tumor Necrosis Factor Alpha Responses in Primary Macrophages
J. Virol.,
September 15, 2003;
77(18):
10125 - 10130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Amyes, C. Hatton, D. Montamat-Sicotte, N. Gudgeon, A. B. Rickinson, A. J. McMichael, and M. F.C. Callan
Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection
J. Exp. Med.,
September 15, 2003;
198(6):
903 - 911.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
